Immunotherapy for infection and malignancy in children with cancer.
Frost
J D
JD
Department of Pediatrics, University of Wisconsin, Madison.
Sondel
P M
PM
D000465:Algorithms; D000911:Antibodies, Monoclonal; D002648:Child; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D006801:Humans; D007108:Immune Tolerance; D016867:Immunocompromised Host; D007167:Immunotherapy / Q000379:methods*; D016233:Immunotherapy, Active; D016219:Immunotherapy, Adoptive; D007239:Infections / Q000150:complications / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D009369:Neoplasms / Q000150:complications / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D012307:Risk Factors; D014613:Vaccines, Attenuated / Q000627:therapeutic use; D015164:Vaccines, Inactivated / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated